Mohawk Industries
MHK
$152.58
+0.56%
Mohawk Industries is the world's largest flooring manufacturer, producing carpet, rugs, ceramic and porcelain tile, laminate, wood, luxury vinyl tile, and vinyl flooring through three reporting segments — Global Ceramic, Flooring North America, and Flooring Rest of the World — serving both residential remodeling and commercial/new-construction channels, with the United States as its largest market alongside Europe and Latin America. The company is a scale-driven, vertically integrated consolidator in a highly fragmented, cyclical industry, competing on manufacturing footprint, distribution breadth, and brand portfolio (including Dal-Tile, Mohawk, and Marazzi) rather than on premium pricing. The current investor narrative centers on an earnings recovery story: after a multi-year housing-driven volume trough, Mohawk has posted three consecutive quarters of improving gross margins (23.5% → 26.6% → 25.5%) and a sharp Q3 EPS beat that drove the stock to new 52-week highs in early November 2026, with sell-side sentiment beginning to shift (Evercore upgraded to Outperform on November 2). The debate now is whether margin recovery from restructuring, cost actions, and modest volume stabilization can be sustained into a still-weak residential housing backdrop, and whether the recent re-rating has already discounted the cyclical rebound.…
MHK
Mohawk Industries
$152.58
Investment Opinion: Should I buy MHK Today?
Rating: Hold. Mohawk is a credible cyclical earnings-recovery story — three straight quarters of gross-margin expansion (23.5% → 26.6% → 25.5%), Q3 EPS of $2.73 versus $0.68 in Q4 2025, and $891.5 million of TTM free cash flow — but at $150.52 the stock has already rallied 40.83% over one year and 26.30% in a single month, leaving it above the $149.13 average analyst target (implied -0.9% downside) and with 9 of 15 analysts at Hold and one Sell. The core reasoning: fundamentals are improving faster than revenue (+1.02% YoY in Q3), but the price now embeds much of that recovery, so the risk/reward is balanced rather than compelling.
Supporting evidence for holding rather than chasing: the forward PE of 15.46x on consensus EPS of $13.11 and EV/EBITDA of 7.36x still sit at a roughly 20–40% discount to a furnishings peer set at mid-to-high single-digit EV/EBITDA and 1.0–1.5x PS, and the 0.81x price-to-book is below book value. Operating margin has climbed from 4.10% in Q1 to 8.48% in Q2 and 6.74% in Q3 versus roughly 3.7% for full-year 2025, while Q3 free cash flow of $390.3 million on just $80.9 million of capex funded $260.9 million of buybacks and $130.1 million of debt repayment, shrinking diluted shares from 62.9 million to 60.0 million. Debt-to-equity of 0.293 and a current ratio of 2.19 mean the recovery is not balance-sheet constrained, and the $183 high target implies 21.6% upside if housing volumes inflect.
Risks that could invalidate the thesis: first, gross margin already slipped sequentially from 26.6% to 25.5%, so a Q4 rollback toward the 23.5% Q1 level would expose the 18.34x trailing PE as expensive for a business with 3.43% TTM net margin and 4.42% ROE. Second, the 63% spread between the $112 low and $183 high targets, plus RBC's October 7 downgrade to Underperform, shows genuine disagreement on durability. Third, with a beta of 1.176 and a 5.47-day short ratio, a market pullback would hit disproportionately. This Hold would upgrade to Buy if Q4 gross margin holds above roughly 25% with revenue growth accelerating past 3%, or on a pullback toward the $139–$140 support shelf; it would downgrade to Sell if gross margin falls back below 24% or residential volumes deteriorate again. Verdict: fairly valued to modestly stretched after the re-rating — not overvalued on forward earnings, but no longer the discount it was at $100 in May.
Sign up to view all
MHK 12-Month Price Forecast
Mohawk's fundamentals are genuinely improving — Q3 EPS of $2.73 versus $0.68 in Q4 2025, operating margin up from 4.10% to 6.74% over three quarters, and $891.5 million of TTM free cash flow — but the stock's 26.30% one-month and 40.83% one-year gains have closed most of the valuation gap, leaving it above the $149.13 consensus target and just 3.4% below its $155.88 52-week high. The 15.46x forward PE on $13.11 consensus EPS is undemanding for a business with this cash generation and balance-sheet strength, yet the 3.43% TTM net margin and 4.42% ROE mean the equity is still earning very little if the recovery stalls. The wide $112–$183 target range and the 9 Hold ratings reflect a market waiting for proof that Q3's margin beat is structural rather than a one-quarter anomaly. I would upgrade to bullish if Q4 gross margin holds above 26% with revenue growth accelerating past 3%, and downgrade to bearish if gross margin falls below 24% or housing data deteriorates further.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Mohawk Industries's 12-month outlook, with a consensus price target around $149.13 and implied upside of -2.3% versus the current price.
Average Target
$149.13
16 analysts
Implied Upside
-2.3%
vs. current price
Analyst Count
16
covering this stock
Price Range
$112 - $183
Analyst target range
Coverage is solid with 15 analysts: 6 Buy, 9 Hold, and 1 Sell, yielding a consensus recommendation of "buy" (mean score 2.31 on a 1–5 scale, where lower is more bullish) and an average target price of $149.13 — essentially at the current price of $150.52, implying roughly -0.9% downside to consensus. That is a telling signal: despite the strong "buy" label, the average target has been left behind by the stock's 26% one-month rally, meaning the consensus is now effectively neutral on near-term upside and the stock is trading at or slightly above where the average analyst sees fair value. The consensus therefore leans cautiously bullish on fundamentals but neutral on price.
The target range of $112.00 to $183.00 is wide — a 63% spread from low to high — signaling genuine disagreement about the durability of the margin recovery. The high target of $183 implies roughly 21.6% upside and would require multiple expansion toward 14x forward EPS plus confidence that housing volumes inflect; the low target of $112 implies about 25.6% downside and prices in a stall in margin recovery, renewed volume deterioration, or a housing-led recession. Recent rating actions show a mixed but improving tone: Evercore ISI upgraded to Outperform from In Line on November 2, Truist maintains Buy, while RBC Capital downgraded to Underperform from Sector Perform on October 7 and Baird, Barclays, and Wells Fargo remain Neutral/Equal Weight — a pattern of cautious optimism where the bulls are momentum-driven and the hold-rated majority is waiting for confirmation that Q3's margin beat is sustainable rather than a one-quarter anomaly.
Bulls vs Bears: MHK Investment Factors
The bull case currently has stronger evidence: three consecutive quarters of margin expansion, a $2.73 Q3 EPS versus $0.68 in Q4 2025, $891.5 million of TTM free cash flow, and a 15.46x forward PE that still sits at a discount to peers. The bear case is not about fundamentals deteriorating but about price — the stock has already rallied 40.83% in a year and 26.30% in a month, leaving it at $150.52 versus an average analyst target of $149.13 and just 3.4% below its 52-week high. The single most important tension is whether the margin recovery is structural (restructuring and cost actions delivering durable operating leverage) or cyclical and temporary (a one-quarter beat in a still-weak housing market); if Q4 margins hold above roughly 25% and volumes stabilize, the re-rating has room to continue toward the $183 high target, but if margins roll over, the stock has 25%+ of downside to the $112 low target.
Bullish
- Margin recovery is real and accelerating: Gross margin expanded from 23.5% in Q1 2026 to 26.6% in Q2 and 25.5% in Q3, while operating margin climbed from 4.10% to 8.48% and 6.74% — versus roughly 3.7% for full-year 2025. Q3 EPS of $2.73 versus $0.68 in Q4 2025 shows operating leverage from restructuring and cost actions is translating directly to the bottom line.
- Valuation still discounts a partial recovery: At 15.46x forward PE on consensus EPS of $13.11 and 7.36x EV/EBITDA, MHK trades at a roughly 20–40% discount to a furnishings peer set at mid-to-high single-digit EV/EBITDA and 1.0–1.5x PS. The 0.81x price-to-book is below book value despite a 40.83% one-year rally, leaving room for re-rating as ROE (currently 4.42%) normalizes.
- Fortress balance sheet with heavy buybacks: Debt-to-equity of 0.293 and a current ratio of 2.19 underpin a TTM free cash flow of $891.5 million, with Q3 alone generating $390.3 million of FCF on just $80.9 million of capex. Management deployed $260.9 million into buybacks and $130.1 million into debt repayment in Q3 from internal cash, shrinking the diluted share count from 62.9 million a year ago to 60.0 million.
- Powerful relative strength and momentum: MHK is up 26.30% in one month versus SPY's -4.99% (a +31.29 point relative spread) and 44.97% over six months versus SPY's -0.54%. The stock sits at 92.7% of its 52-week range ($92.99–$155.88), and Evercore's November 2 upgrade to Outperform suggests sell-side sentiment is beginning to turn.
Bearish
- Consensus target implies zero upside: The average analyst target of $149.13 sits below the current $150.52 price, implying -0.9% downside, and 9 of 15 analysts rate the stock a Hold with one Sell. The stock's 26% one-month rally has outrun the sell-side's fair value estimates, meaning the consensus is now effectively neutral on near-term price.
- Revenue growth is barely positive: Q3 2026 revenue of $2.786 billion grew just 1.02% YoY, and the sequential pattern ($2.729B → $2.991B → $2.786B) reflects seasonality rather than accelerating demand. With residential housing turnover still weak and the North American soft-surface business a drag, the thesis rests entirely on cost-driven margin expansion, which caps the multiple the market should pay.
- Parabolic move invites mean reversion: The stock jumped roughly 18% in four sessions (from $129.99 on October 29 to $153.36 on November 4), a vertical slope that often precedes consolidation. With a beta of 1.176 and a 5.47-day short ratio, a 10% SPY correction could plausibly translate into a 12–15% MHK decline as crowded positioning unwinds.
- Wide analyst dispersion signals uncertainty: The $112 to $183 target range is a 63% spread, with the low target implying about 25.6% downside and pricing in a stall in margin recovery or a housing-led recession. RBC's October 7 downgrade to Underperform and Neutral stances from Baird, Barclays, and Wells Fargo show the hold-rated majority is waiting for proof Q3's beat is sustainable rather than a one-quarter anomaly.
MHK Technical Analysis
MHK is in a powerful, sustained uptrend: the stock is up 40.83% over the past year and 37.45% year-to-date, and at $150.52 it sits at roughly 92.7% of its 52-week range of $92.99–$155.88 — just 3.4% below the high. That positioning signals strong momentum but also meaningful overextension risk, particularly given the stock has already re-rated well ahead of a confirmed housing recovery. The 52-week low of $92.99 implies a maximum drawdown of -31.1% from prior highs, underscoring that this is a high-beta cyclical that can give back gains quickly when the macro narrative shifts.
Short-term momentum is accelerating decisively and diverging positively from the broader market: MHK is up 26.30% over the past month versus a -4.99% decline in SPY, a relative strength spread of +31.29 percentage points, and up 10.63% over three months against SPY's -4.91% (relative strength +15.54). The 6-month gain of 44.97% (relative strength +45.51) confirms this is not a one-month spike but a sustained re-rating, with the sharpest leg occurring in the final week of October and first week of November (from $129.99 on Oct 29 to $153.36 on Nov 4, a ~18% move in four sessions) — a parabolic burst that often precedes short-term consolidation. The 1-month trend is clearly confirming, not conflicting with, the 1-year trend, which argues for trend continuation but also raises the odds of a mean-reversion pullback given the vertical slope.
Key technical levels: immediate resistance is the 52-week high at $155.88, and a clean breakout above that level on volume would signal the market is pricing in a full cyclical earnings recovery and likely invite momentum-chasing flows toward the $160s. Support sits at the $139–$140 shelf (the August consolidation zone and the October 30 breakout level), with the 52-week low at $92.99 as the ultimate floor. With a beta of 1.176, MHK is roughly 18% more volatile than the market, meaning position sizing should account for amplified drawdowns — a 10% SPY correction could plausibly translate into a 12–15% MHK decline, and the elevated short ratio of 5.47 days-to-cover suggests some crowded short positioning that could amplify moves in either direction.
Beta
1.18
1.18x market volatility
Max Drawdown
-31.1%
Largest decline past year
52-Week Range
$93-$159
Price range past year
Annual Return
+40.2%
Cumulative gain past year
| Period | MHK Return | S&P 500 |
|---|---|---|
| 1m | +30.0% | -2.4% |
| 3m | +9.7% | -2.3% |
| 6m | +58.0% | +2.8% |
| 1y | +40.2% | +11.3% |
| ytd | +39.3% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MHK Fundamental Analysis
Revenue growth is modest but stabilizing: Q3 2026 revenue of $2.786 billion grew just 1.02% year-over-year, following $2.991 billion in Q2 and $2.728 billion in Q1, against a year-ago Q3 base of $2.758 billion. The sequential pattern ($2.729B → $2.991B → $2.786B) shows normal seasonality rather than accelerating demand, and the low-single-digit YoY growth confirms the company is still fighting a soft residential housing market. Segment mix shows Global Ceramic at $1.110 billion, Carpet and Resilient at $959 million, and Laminate and Wood at $442 million — ceramic remains the largest and most globally diversified driver, while the North American soft-surface business remains the drag tied to housing turnover. The investment case therefore rests on margin recovery rather than top-line growth, which caps the multiple the market should be willing to pay.
Profitability is improving meaningfully off a depressed base: Q3 2026 net income was $163.1 million (5.85% net margin) on gross profit of $709.7 million (25.47% gross margin), up from Q1's $117.1 million (4.29% margin) and $641.9 million gross profit (23.52% margin), and well ahead of the year-ago Q3's $108.9 million. Gross margin has expanded from 23.5% in Q1 to 26.6% in Q2 and 25.5% in Q3, while operating margin improved from 4.10% in Q1 to 8.48% in Q2 and 6.74% in Q3 — a clear upward trajectory versus 2025's full-year operating margin of roughly 3.7%. The TTM figures (net margin 3.43%, operating margin 4.73%, gross margin 23.87%) still look thin for an industrial manufacturer, reflecting the depth of the prior trough, but the quarterly run-rate of ~$2.73 EPS in Q3 versus $0.68 in Q4 2025 shows operating leverage is real and the restructuring actions are bearing fruit.
Balance sheet health is solid and cash generation is robust: debt-to-equity is just 0.293, the current ratio is 2.19, and TTM free cash flow is $891.5 million, with Q3 alone generating $390.3 million of FCF on $471.2 million of operating cash flow against only $80.9 million of capex. The company returned capital aggressively in Q3 — $260.9 million of stock repurchases plus $130.1 million of debt repayment — funded entirely from internal cash flow, with cash at period-end of $816.8 million. ROE of 4.42% and ROA of 3.85% remain depressed relative to the company's historical norms (ROE was ~10.5% in the 2023 down-cycle and higher pre-2022), which is precisely the recovery lever: as margins normalize, ROE should expand materially without any balance-sheet strain, and the low leverage gives management ample capacity to keep buying back stock.
Quarterly Revenue
$2.8B
2026-10
Revenue YoY Growth
+1.0%
YoY Comparison
Gross Margin
25.5%
Latest Quarter
Free Cash Flow
$891500000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MHK Overvalued?
Because net income is positive ($163.1 million in Q3, TTM EPS of $0.054 on a reported basis but ~$2.73 quarterly run-rate), the PE ratio is the appropriate primary metric. The trailing PE of 18.34x versus a forward PE of 15.46x implies the market expects roughly 19% earnings growth over the next twelve months — consistent with the analyst consensus EPS estimate of $13.11 for the forward period and the margin-recovery trajectory. The gap between trailing and forward multiples is moderate rather than dramatic, suggesting the market is pricing in continued but not explosive earnings normalization.
On peer comparison, MHK trades at a PS of 0.63x, EV/Sales of 0.906x, and EV/EBITDA of 7.36x — all at the low end for a scaled building-products manufacturer, and its PB of 0.81x means the stock trades below book value despite the recent rally. Against a furnishings/fixtures peer set that typically commands mid-to-high single-digit EV/EBITDA and 1.0–1.5x PS, MHK's 7.36x EV/EBITDA and 0.63x PS represent a discount of roughly 20–40%, which is arguably justified by its below-peer net margin (3.43%) and ROE (4.42%) but leaves room for re-rating as margins recover. The forward PE of 15.46x against an estimated EPS of $13.11 is undemanding for a business with $891.5 million of TTM free cash flow and a 0.29 debt-to-equity ratio.
Historically, MHK's PE has ranged from single digits (9.2x in Q2 2026, 11.6x in Q3 2026) to over 40x during earnings troughs (40.2x in Q4 2025), and its PS has ranged from roughly 2.2x to 3.7x over the past several years — the current reported PS of 0.63x appears anomalously low relative to that history, likely reflecting a market-cap/segment data mismatch, but on the historical-ratio series the stock has consistently traded between 0.7x and 1.0x book value during the 2024–2026 down-cycle. At 0.81x PB, MHK sits in the middle of that band — not a deep-value opportunity but not stretched either — while the trailing PE of 18.3x is above the 9–12x trough multiples seen in 2026 but far below the 40x peak, suggesting the market has priced in a partial, not full, recovery.
PE
18.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 7x~25x
vs. Industry Avg
24.3x
Industry PE ~24.3x*
EV/EBITDA
7.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the fact that the entire thesis rests on margin expansion rather than revenue growth. Q3 revenue grew only 1.02% YoY to $2.786 billion, and TTM net margin of 3.43% and operating margin of 4.73% remain thin for a scaled industrial, meaning a modest cost or pricing setback could erase a large share of earnings. Gross margin already slipped sequentially from 26.6% in Q2 to 25.5% in Q3, and the business is concentrated in cyclical residential remodeling and new construction, with the North American soft-surface segment acting as a persistent drag. Balance-sheet risk is low — debt-to-equity of 0.293, current ratio of 2.19, and $816.8 million of cash — but the low ROE of 4.42% means the equity base is currently earning very little, so any failure of the recovery leaves the valuation without fundamental support.
Market and competitive risks are dominated by valuation compression after a sharp re-rating. At $150.52 the stock trades at 92.7% of its 52-week range and above the $149.13 average analyst target, with 9 of 15 analysts at Hold and RBC downgraded to Underperform on October 7 — a sign the sell-side sees limited near-term upside. The 63% spread between the $112 low and $183 high targets reflects genuine disagreement about durability, and with a beta of 1.176, MHK is roughly 18% more volatile than the market, so a sector rotation away from cyclicals or a housing data miss would hit disproportionately. The 5.47-day short ratio adds two-way amplification risk, and the stock's 26.30% one-month gain against SPY's -4.99% makes it vulnerable to profit-taking if momentum funds rotate.
The worst-case scenario is a housing-led demand stall combined with margin recovery reversing: if Q4 gross margin falls back toward the 23.5% Q1 level and residential volumes deteriorate, the market would re-price MHK as a low-return cyclical rather than a recovery story. In that chain of events, the stock could retrace toward the $112 analyst low target, roughly -25.6% from $150.52, and in a deeper housing recession toward the 52-week low of $92.99, a drawdown of about -38.2%. The historical max drawdown of -31.1% provides a realistic benchmark for how much this high-beta name can give back when the macro narrative shifts, meaning an investor could lose 25–38% from current levels in an adverse scenario.
FAQ
Ranked by severity: first, margin-durability risk — gross margin already slipped sequentially from 26.6% in Q2 to 25.5% in Q3, and a Q4 rollback toward the 23.5% Q1 level would invalidate the recovery thesis and expose the 18.34x trailing PE against a 3.43% net margin. Second, housing-cycle risk — Q3 revenue grew only 1.02% YoY to $2.786 billion, and further deterioration in residential turnover would hit the North American soft-surface segment directly. Third, valuation and momentum risk — the stock trades above the $149.13 average target with 9 of 15 analysts at Hold, and after an 18% four-session surge from $129.99 to $153.36, profit-taking is a live threat. Fourth, macro/beta risk — with a beta of 1.176 and a 5.47-day short ratio, a 10% SPY correction could plausibly translate into a 12–15% MHK decline, with the 52-week low of $92.99 (-38.2%) as the tail-risk floor.
The base case (55% probability) targets $140–$155, assuming Q4 gross margin holds in the 24.5–26.5% band, revenue growth stays at 1–3% YoY, free cash flow remains near the $891.5 million run-rate, and the 9 Hold ratings cap multiple expansion near 15–16x forward EPS — consistent with the $149.13 average analyst target. The bull case (25%) targets $170–$183, requiring gross margin sustainably above 27%, a housing-turnover inflection in 2027, and multiple expansion toward 14x forward EPS, aligned with the $183 high target. The bear case (20%) targets $112–$125, driven by a Q4 gross margin drop below 24%, further housing deterioration, and momentum unwinding, aligned with the $112 analyst low target. The base case is most likely; its key assumption is that the Q3 margin beat proves structural rather than a one-quarter anomaly.
On forward earnings MHK looks modestly undervalued, but on trailing profitability it is fairly valued to slightly stretched. The 15.46x forward PE on $13.11 consensus EPS and 7.36x EV/EBITDA compare favorably with a peer set at mid-to-high single-digit EV/EBITDA and 1.0–1.5x PS, and the 0.81x P/B is below book value. Yet the 18.34x trailing PE is well above the 9–12x trough multiples seen earlier in 2026, and the 3.43% TTM net margin and 4.42% ROE are thin for a scaled industrial, so the discount is partly earned rather than a pure mispricing. The gap between trailing and forward multiples implies the market expects roughly 19% earnings growth, meaning investors are paying for continued margin normalization, not for a full housing recovery. Verdict: fairly valued to modestly stretched after the re-rating — not overvalued on forward earnings, but no longer the deep discount it was near $100 in May.
The risk/reward is balanced rather than compelling at $150.52. On the positive side, the stock trades at 15.46x forward EPS of $13.11 and 7.36x EV/EBITDA — a roughly 20–40% discount to furnishings peers — with 0.81x P/B below book value, $891.5 million of TTM free cash flow, and debt-to-equity of just 0.293. However, the average analyst target of $149.13 sits below the current price (about -0.9% implied), 9 of 15 analysts rate it Hold with one Sell, and the stock has already gained 26.30% in a month and 40.83% in a year, leaving it just 3.4% below its $155.88 high. The biggest downside risk is a margin rollback that would take the stock toward the $112 low target, roughly -25.6%. It is a reasonable buy for long-horizon investors who want cyclical housing exposure and can tolerate a 25–38% drawdown, ideally accumulating on a pullback toward the $139–$140 support shelf rather than chasing the parabolic move.
MHK is better suited to a medium-to-long-term holding than to short-term trading. It pays no dividend (0% yield, 0% payout ratio), so total return depends entirely on earnings recovery and multiple re-rating, and its beta of 1.176 plus a -31.1% historical max drawdown make it a volatile vehicle for short-term positioning — especially after a 26.30% one-month move that leaves it above the consensus target. Earnings visibility is improving but still limited: three quarters of margin expansion (23.5% → 26.6% → 25.5%) and Q3 EPS of $2.73 versus $0.68 in Q4 2025 show real operating leverage, yet revenue growth of just 1.02% YoY means the trajectory hinges on housing data outside management's control. A minimum holding period of 12–24 months is appropriate to capture the cyclical recovery through a full housing cycle, with position sizing that accounts for a potential 25–38% drawdown in an adverse scenario.